[Hypokalemic myopathy and metabolic alkalosis secondary to the topical application of 9-alpha-fluoroprednisolone].
D000287:Administration, Topical; D000328:Adult; D000471:Alkalosis / Q000139:chemically induced*; D005477:Fluprednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced*; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced*
D005477:Fluprednisolone
Miopatía hipokaliémica y alcalosis metabólica secundarias a aplicación tópica de 9-alfa-flúor-prednisolona.